Request Discount

Allergy Vaccine Market (Allergy Type - Allergic Asthma, Peanut Hypersensitivity, Seasonal Allergic Rhinitis, Grass Pollen Hypersensitivity, Tree Pollen Hypersensitivity, Cat Dander Allergy, and Other Allergy Type; Vaccine Type - Cat Allergy Vaccine, Peanut Allergy Vaccine, House Dust Mite Allergy Vaccine, Injectable MPL Allergy Vaccine, Ragweed Allergy Immunotherapy Vaccine, and Other Vaccine Type): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

  • Published : October, 2019

  • Rep Id : HC0751

  • Category : Healthcare & Medical Devices

  • Status : Published

This report provides exclusive insights into the COVID-19 impact on the Allergy Vaccine Market. The detailed analysis provides information about the impact of the outbreak on the demand and supply conditions, trends and forecasts of the Allergy Vaccine Market. Moreover, the impact analysis covers the study of the COVID-19 on the supply chain of Allergy Vaccine Market. The sectoral impact shall provide insights into both short term and long term effects of the pandemic on the related and support industries.

A recent report published by Infinium Global Research on the allergy vaccine market provides an in-depth analysis of segments and sub-segments in the global as well as regional allergy vaccine market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional allergy vaccine market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global allergy vaccine market. According to the report, the global allergy vaccine market is projected to grow at a healthy CAGR over the forecast period of 2019-2025.


Market Insight

The condition caused by the misguided reaction of the immune system to harmless or foreign substances i.e allergens is known as allergy. It can be due to food, inject into the body or due to inhalation into the lungs. Common types of allergies include allergic asthma, drug allergy, food allergy, allergic rhinitis, etc. Allergy caused by allergens may lead to symptoms such as vomiting, sneezing, peeling skin, running nose and itchy eyes. In extreme conditions, it may also cause rashes, breathing trouble, low blood pressure, and hives. Few allergies like anaphylaxis can be life-threatening.


Growing prevalence of the allergic disease is one of the major cause driving the growth of allergy vaccine market. Based on the report published by AAFA more than 50 million Americans are suffering from various types of allergies each year and it has become the 6th leading cause of chronic illness in the United States. furthermore, a report published by World Allergy Organization (WAO) Allergies and related diseases including asthma, rhinosinusitis, atopic dermatitis and life-threatening food, drug, and stinging insect allergies affects at least 30% of the population and nearly 80% of families. Moreover, new research activities for the development of allergy vaccines by private and government industries are also contributing to the growth of the market. On the other hand, high costs associated with the vaccines and the presence of limited manufactures can hamper the growth of the market. However, growing awareness about the allergy disease and their treatment among the people globally will provide a better opportunity for the growth of the market in the forecast period.


Geographically the allergy market is divided into North America, Europe, Asia-Pacific, and RoW. North America is expected to dominate the market in the forecast period, followed by Europe. Growing cases of allergy diseases in these regions will contribute to the high demand for allergy vaccines in the future period. The Asia Pacific region is the emerging market for the allergy vaccine market. Based on the stats provided by the Asia Pacific Association of Allergy (APAAACI) in Asia-Pacific, the prevalence of allergic rhinitis is variously reported as ranging from around 8–10% of the population in Korea to more than 50% among adults in Vietnam and Thailand.


Segment Covered

The report on the global allergy vaccine market covers segments such as allergy type, and vaccine type. On the basis of allergy type, the sub-markets include allergic asthma, peanut hypersensitivity, seasonal allergic rhinitis, grass pollen hypersensitivity, tree pollen hypersensitivity, cat dander allergy, and other allergy types. On the basis of vaccine type, the sub-markets include cat allergy vaccine, peanut allergy vaccine, house dust mite allergy vaccine, injectable MPL allergy vaccine, ragweed allergy immunotherapy vaccine, and other vaccine types.


Companies Profiled:

The report provides profiles of the companies in the market such as Circassia, Cytos Biotechnology AG, DBV Technologies SA, Allertein Therapeutics, Stallergenes Greer plc, Merck & Co., Inc., Allergy Therapeutics, and Novartis International AG.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of allergy vaccine market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount